Cytokinetics

Cardiovascular Account Specialist - U.S. Sales, Phoenix North, AZ

Remote

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Position Overview

  • Location Type: Territory-Based (Includes Scottsdale, AZ and Glendale, AZ)
  • Employment Type: Full Time
  • Salary: (Salary information not provided in the text)

This role is with Cytokinetics, a late-stage biopharmaceutical company focused on developing muscle activators and inhibitors for cardiovascular diseases. The Cardiovascular Account Specialist will be responsible for launching a novel cardiac myosin inhibitor for Hypertrophic Cardiomyopathy (HCM) within a designated territory, building relationships with key stakeholders, and driving sales performance.

Requirements

  • Education: Bachelor’s Degree required
  • Experience: 5+ years of experience in biotech/pharma sales
  • Territory Ownership: Experience as a rep with sole ownership of the territory is highly preferred.
  • Preferred Experience:
    • Cardiology, rare disease, or specialty product experience
    • Specialty product launch experience

Responsibilities

  • Sales Performance: Deliver sales results and operate autonomously within the territory.
  • Account Planning: Develop territory-specific account plans to identify and prioritize opportunities.
  • Stakeholder Collaboration: Work synergistically with internal stakeholders (medical, payer, patient navigation/support) and external customers (IDNs, hospitals, cardiology clinics, specialty pharmacies).
  • Subject Matter Expertise: Serve as a subject matter expert and resource to customers, providing clinically relevant information about the product and disease.
  • Demand Generation: Communicate approved resources to healthcare professionals (HCPs) to create demand for the product launch, including marketing materials, payer information, formulary coverage, and patient support services.
  • Patient Support: Focus on creating demand for HCM patients.

Application Instructions

  • (Application instructions not provided in the text)

Company Information

  • Company: Cytokinetics
  • Industry: Specialty Cardiovascular Biopharmaceutical
  • Focus: Discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors.
  • Core Values:
    • Patients are our North Star
    • Science is in our Soul
    • We > Me
    • Make it Happen

Skills

Biotech Sales
Pharmaceutical Sales
Cardiology
Rare Disease
Specialty Product Launch
Account Planning
Stakeholder Collaboration
Clinical Knowledge
Demand Generation
Patient Support

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Risks

Increased competition could impact market share and profitability.
Potential delays in clinical trials could hinder drug commercialization.
Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
The company has a robust pipeline including omecamtiv mecarbil and aficamten.
Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.
Strategic partnerships, like with Sanofi, expand market reach and potential revenue.
Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI